Johannes Gutenberg-Universität Mainz
- 6131/39-0
Eckes, Stefanie; Braun, Joy; Wack, Julia S. et al.
Rose Bengal Crosslinking to Stabilize Collagen Sheets and Generate Modulated Collagen LaminatesINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 21. H. 19. 2020
Zeiser, Robert; von Bubnoff, Nikolas; Butler, Jason et al.
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseNEW ENGLAND JOURNAL OF MEDICINE. Bd. 382. H. 19. 2020 S. 1800-1810
Bassetti, Davide; Hammann, Jens; Luhmann, Heiko J. et al.
Ryanodine receptor- and sodium-calcium exchanger-mediated spontaneous calcium activity in immature oligodendrocytes in culturesNEUROSCIENCE LETTERS. Bd. 732. 2020
Daiber, Andreas; Oelze, Matthias; Vujacic-Mirski, Ksenija et al.
S-Nitrosation and denitrosation of proteins by variation of superoxide/nitric oxide ratio - implications for prevention of sulfoxidation-dependent enzyme inactivation during ischemia/reperfusionFASEB JOURNAL. Bd. 34. 2020
Bremerich, D.; Annecke, T.; Chappell, D. et al.
S1 Guideline: Obstetric analgesia and anaesthesiaANASTHESIOLOGIE & INTENSIVMEDIZIN. Bd. 61. 2020 S. S300-S338
Monig, Stefan; Ott, Katja; Gockel, Ines et al.
S3 guidelines on gastric cancer-diagnosis and treatment of adenocarcinoma of the stomach and esophagogastric junction Version 2.0-August 2019. AWMF register number: 032/009OLCHIRURG. Bd. 91. H. 1. 2020 S. 37-40
Hopf, Susanne; Nowak, Caroline; Hennermann, Julia B. et al.
Saccadic reaction time and ocular findings in phenylketonuriaORPHANET JOURNAL OF RARE DISEASES. Bd. 15. H. 1. 2020
Beck, Olaf; Paret, Claudia; Russo, Alexandra et al.
Safety and Activity of the Combination of Ceritinib and Dasatinib in OsteosarcomaCANCERS. Bd. 12. H. 4. 2020
Rommens, Pol Maria; Nolte, Eva Mareike; Hopf, Johannes et al.
Safety and efficacy of 2D-fluoroscopy-based iliosacral screw osteosynthesis: results of a retrospective monocentric studyEUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY. 2020
Zoulim, Fabien; Fournier, Claire; Habersetzer, Francois et al.
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trialHUMAN VACCINES & IMMUNOTHERAPEUTICS. Bd. 16. H. 2. 2020 S. 388-399